Share price has certainly picked up this week. Bioshares in it's latest edition has Acrux as one of it's top 5 stock picks.
Bioshares Comments:
Acrux has appointed Credit Suisse as a corporate advisor to assist with the commercialization of the company's Axiron product. That Acrux has selected Credit Suisse rather than a more traditional biotech investment bank would suggest that an outright acquistion of the company is more likely than a licensing deal for Axiron. It would also seem to suggest that interest in Axiron and in Acrux is escalating and that the company needs assistance to negotiate the sale or license of company assets.
Perhaps these comments from Bioshares have been a driver of ACR's share price this week
- Forums
- ASX - By Stock
- ACR
- price capping
ACR
acrux limited
Add to My Watchlist
10.0%
!
1.8¢

price capping, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
-0.002(10.0%) |
Mkt cap ! $7.366M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $8.471K | 470.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 370600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 691823 | 0.017 |
10 | 960173 | 0.016 |
5 | 1311882 | 0.015 |
2 | 140000 | 0.014 |
3 | 486850 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 370600 | 1 |
0.021 | 111922 | 1 |
0.022 | 100000 | 1 |
0.023 | 381179 | 1 |
0.024 | 201073 | 3 |
Last trade - 13.32pm 25/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online